1. Home
  2. Live Updates
  3. Retina service

Live Breaking News & Updates on Retina service

Stay informed with the latest breaking news from Retina service on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Retina service and stay connected to the pulse of your community

Ocugen Announces Dosing Completion of Subjects with

MALVERN, Pa., April 19, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering,...

United-states , Americans , Syedm-shah , Exchange-commission , Ocugen-inc , Linkedin , Head-of-communications , Retina-service-at-gundersen-health-system , Huma-qamar , Chief-medical-officer , Vice-chair

Ocugen Announces Dosing Completion of Subjects with Geographic Atrophy in Cohort 2 of Phase 1/2 ArMaDa Clinical Trial of OCU410—A Modifier Gene Therapy

MALVERN, Pa., April 19, 2024 -- Ocugen, Inc. , a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines, today announced that...

United-states , Americans , Syedm-shah , Linkedin , Head-of-communications , Exchange-commission , Ocugen-inc , Retina-service-at-gundersen-health-system , Huma-qamar , Chief-medical-officer , Vice-chair

Ocugen (OCGN) Announces Dosing Completion of Subjects with Geographic Atrophy in Cohort 2 of Phase 1/2 ArMaDa Clinical Trial of OCU410—A Modifier Gene Therapy

Ocugen (OCGN) Announces Dosing Completion of Subjects with Geographic Atrophy in Cohort 2 of Phase 1/2 ArMaDa Clinical Trial of OCU410—A Modifier Gene Therapy
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states , Syedm-shah , Ocugen-inc , Retina-service-at-gundersen-health-system , Huma-qamar , Chief-medical-officer , Vice-chair , Digital-medicine , Retina-service , Gundersen-health-system , Safety-monitoring-board

Ocugen Announces Dosing Completion of Subjects with Geographic Atrophy in Cohort 2 of Phase 1/2 ArMaDa Clinical Trial of OCU410-A Modifier Gene Therapy

Ocugen Announces Dosing Completion of Subjects with Geographic Atrophy in Cohort 2 of Phase 1/2 ArMaDa Clinical Trial of OCU410-A Modifier Gene Therapy
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United-states , Americans , Syedm-shah , Head-of-communications , Retina-service-at-gundersen-health-system , Exchange-commission , Ocugen-inc , Linkedin , Announces-dosing-completion , Geographic-atrophy , Mada-clinical-trial

Aviceda Therapeutics Announces Formation of Renowned European Clinical Advisory Board

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apr 8, 2024--

London , City-of , United-kingdom , Germany , Tel-aviv , Israel , Austria , Vienna , Wien , Cambridge , Cambridgeshire , United-states

Nanoscope Therapeutics Announces Positive Top-line Results from Randomized Controlled Trial of MCO-010 for Retinitis Pigmentosa

MCO-010 achieved its primary and key secondary endpoints with statistical significance and no serious adverse events Data from the Phase 2b RESTORE trial...

Dallas , Texas , United-states , California , Seattle , Washington , David-boyer , Sulagna-bhattacharya , Arshadm-khanani , Samarendra-mohanty , Reno-school-of-medicine , Retina-research

Nanoscope Therapeutics Announces Positive Top-Line Results From Randomized Controlled Trial Of MCO-010 For Retinitis Pigmentosa

Nanoscope Therapeutics Announces Positive Top-Line Results From Randomized Controlled Trial Of MCO-010 For Retinitis Pigmentosa
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Dallas , Texas , United-states , Washington , California , Seattle , Samarendra-mohanty , David-boyer , Arshadm-khanani , Sulagna-bhattacharya , National-eye , Clinical-research-at-sierra-eye-associates

New Method to Diagnose Eye Stroke Developed

An innovative protocol diagnosing eye strokes, aiming to save vision has been developed by researchers.

New-york , United-states , Richardb-rosen , Mount-sinai-health-system , Eye-stroke-service , Mount-sinai-department-of-ophthalmology , Retina-service , Mount-sinai-health , Sudden-vision-loss , Potential-sign , Eye-stroke-painless

Mount Sinai Creates Fast Protocol for Eye Stroke Diagnosis

Mount Sinai Creates Fast Protocol for Eye Stroke Diagnosis
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Long-island , Florida , United-states , New-york , Westchester , Richardb-rosen , Gareth-lema , Eye-stroke-service , Health-system , Mount-sinai-department-of-ophthalmology , Mount-sinai-health-system , New-york-eye

Mount Sinai Ophthalmologists Develop Novel Protocol to Rapidly Diagnose and Treat Eye Stroke

Study shows using advanced technology and time can prevent permanent vision loss

Long-island , Florida , United-states , Westchester , New-york , Gareth-lema , Richardb-rosen , Eye-stroke-service , Mount-sinai-department-of-ophthalmology , Health-system , Mount-sinai-health-system , Sinai-ophthalmologists-develop-novel-protocol